By contrast, the CD276 protein is overexpressed in many types of malignancies (breast cancer, lung cancer, ovarian cancer, brain tumors, gastric cancer, and squamous cell carcinoma) and is correlated with poor prognosis, increased tumor grade and metastasis, drug resistance, recurrence rate, and decreased OS [26]. Here, CD276 is linked to brain neoplasm.